# Detection of Early Esophageal Cancer by NIR-FME.

> **NCT03877601** · PHASE2 · UNKNOWN · sponsor: **University Medical Center Groningen** · enrollment: 60 (estimated)

## Conditions studied

- Barrett Esophagus

## Interventions

- **DRUG:** Bevacizumab-IRDye800CW
- **DIAGNOSTIC_TEST:** Fluorescence endoscopy

## Key facts

- **NCT ID:** NCT03877601
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-29
- **Primary completion:** 2021-09-01
- **Final completion:** 2021-10-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-11-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03877601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03877601, "Detection of Early Esophageal Cancer by NIR-FME.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03877601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*